By allowing ads to appear on this site, you support the local businesses who, in turn, support great journalism.
Australia’s Largest University Establishes ‘Monash Boston Hub’ to Accelerate Global Biotech Partnerships and Licensing
preview.jpg
Monash university is particularly well known for its work in biotechnology and life sciences, and has numerous industry and institutional partnerships in these areas. Some major drivers of this activity include the Monash Institute of Pharmaceutical Sciences (MIPS), which translates research discoveries into real-world impact. Significant MIPS-led commercialization and research translation projects have resulted in the creation of biotech companies, including Cincera, Septerna, Phrenix, Pacalis, Seaport Therapeutics, and others. MIPS is also a trusted global resource for optimizing promising drug candidates ready for development and commercialization, and has been the driving force behind working with partners to progress more than 40 novel drug candidates into clinical development.
BOSTON & MELBOURNE, Australia--(BUSINESS WIRE)--Oct 2, 2025-- Monash University, Australia’s largest and a top‑50 global research institution, today announced the establishment of the Monash Boston Hub to meet surging demand from North American and European biotech and life sciences companies for Monash drug discovery, clinical trial, and commercialization of its innovations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002504084/en/ Monash university is particularly well known for its work in biotechnology and life sciences, and has numerous industry and institutional partnerships in these areas.